Yuichi Muraki

1.2k total citations
95 papers, 867 citations indexed

About

Yuichi Muraki is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Pharmacology. According to data from OpenAlex, Yuichi Muraki has authored 95 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Applied Microbiology and Biotechnology, 28 papers in Epidemiology and 23 papers in Pharmacology. Recurrent topics in Yuichi Muraki's work include Antibiotic Use and Resistance (44 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Antibiotic Resistance in Bacteria (16 papers). Yuichi Muraki is often cited by papers focused on Antibiotic Use and Resistance (44 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Antibiotic Resistance in Bacteria (16 papers). Yuichi Muraki collaborates with scholars based in Japan, United States and Sweden. Yuichi Muraki's co-authors include Masahiro Okuda, Norio Ohmagari, Masaki Tanabe, Takuya Iwamoto, Tetsuya Yagi, Yoshiki Kusama, Daisuke Yamasaki, Masahiro Ishikane, Yasuhiro Tsuji and M Maeda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yuichi Muraki

86 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuichi Muraki Japan	17	382	236	175	161	119	95	867
Myriam Gharbi United Kingdom	18	264 0.7×	230 1.0×	165 0.9×	135 0.8×	148 1.2×	34	1.3k
Kathryn Dzintars United States	11	382 1.0×	320 1.4×	184 1.1×	187 1.2×	152 1.3×	31	862
Joshua Courter United States	17	234 0.6×	328 1.4×	110 0.6×	268 1.7×	82 0.7×	57	778
Jennifer L. Goldman United States	18	283 0.7×	234 1.0×	146 0.8×	309 1.9×	48 0.4×	105	994
Lucas Schulz United States	20	388 1.0×	314 1.3×	367 2.1×	294 1.8×	119 1.0×	77	1.1k
Robert J. Hunkler United States	23	605 1.6×	373 1.6×	167 1.0×	182 1.1×	81 0.7×	31	1.8k
F Vauzelle-Kervroëdan France	17	260 0.7×	399 1.7×	103 0.6×	258 1.6×	110 0.9×	38	1.3k
Khalid Eljaaly Saudi Arabia	18	187 0.5×	219 0.9×	235 1.3×	204 1.3×	242 2.0×	73	936
Nusrat Shafiq India	19	243 0.6×	116 0.5×	79 0.5×	88 0.5×	106 0.9×	86	1.0k
Minyon Avent Australia	15	189 0.5×	162 0.7×	107 0.6×	230 1.4×	80 0.7×	36	675

Countries citing papers authored by Yuichi Muraki

Since Specialization

Citations

This map shows the geographic impact of Yuichi Muraki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Muraki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Muraki more than expected).

Fields of papers citing papers by Yuichi Muraki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Muraki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Muraki. The network helps show where Yuichi Muraki may publish in the future.

Co-authorship network of co-authors of Yuichi Muraki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Muraki. A scholar is included among the top collaborators of Yuichi Muraki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Muraki. Yuichi Muraki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akazawa, Manabu, et al.. (2025). Current status and challenges of health economic evaluations related to antimicrobial stewardship in Japan: A scoping review up to 2023. Journal of Infection and Chemotherapy. 31(3). 102657–102657. 2 indexed citations

Maeda, M, et al.. (2025). Assignments of antibiotic spectrum coverage scores of antibiotic agents approved in Japan: Utilization of the days of antibiotic spectrum coverage. Journal of Infection and Chemotherapy. 31(4). 102667–102667. 3 indexed citations

Kato, Takaaki, Shuji Inada, Tetsu Shimizu, et al.. (2025). Correlation between carbapenem susceptibility in Pseudomonas aeruginosa and modified antibiotic heterogeneity index: a multicenter observational study using a surveillance platform. Antimicrobial Stewardship & Healthcare Epidemiology. 5(1). e21–e21. 1 indexed citations

Akazawa, Manabu, et al.. (2025). Trends of Strong and Weak Opioid Prescriptions in Japan: A Cross-Sectional Study Based on Open Data from the National Database and Hospital Claims Data from Fiscal Years 2015 to 2021. Biological and Pharmaceutical Bulletin. 48(3). 279–285.

Muraki, Yuichi, et al.. (2025). Home visit survey on outpatient antibiotic use: Assessing leftover medications and factors influencing appropriate use by community Pharmacists. Journal of Infection and Chemotherapy. 31(3). 102623–102623. 1 indexed citations

Muraki, Yuichi, et al.. (2023). Necessity for a System Implementing Therapeutic Drug Monitoring in Outpatient Settings Based on the Actual Use of Voriconazole Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan: A Descriptive Epidemiological Study. Biological and Pharmaceutical Bulletin. 46(10). 1490–1493. 3 indexed citations

Kusama, Yoshiki, Yusuke Asai, Shinya Tsuzuki, et al.. (2023). Effects of population age structure on parenteral antimicrobial use estimations. Scientific Reports. 13(1). 840–840. 1 indexed citations

Maeda, M, et al.. (2023). Relationship between carbapenem use and major diagnostic category in curative care beds: Analysis of a 2020 Japanese national administrative database. Journal of Infection and Chemotherapy. 30(6). 562–566. 1 indexed citations

Nakatani, Takeshi, et al.. (2023). Effectiveness of Noncertified Pharmacist–Led Antimicrobial Stewardship Programs in a Medium-Sized Hospital Without an Infectious Disease Specialist: A Retrospective Pre–Post Study. Open Forum Infectious Diseases. 10(3). ofad116–ofad116. 7 indexed citations

10.

Ito, Saki, et al.. (2022). A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database. Journal of Infection and Chemotherapy. 28(9). 1266–1272. 4 indexed citations

11.

Maeda, M, et al.. (2022). Association between Carbapenem Consumption and Clinical Outcomes in an In-Hospital Setting: Analysis of a Japanese Nationwide Administrative Database in 2020. Antibiotics. 11(12). 1807–1807. 2 indexed citations

12.

Muraki, Yuichi, M Maeda, Masao Takahashi, et al.. (2022). Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First Report. Antibiotics. 11(5). 682–682. 7 indexed citations

13.

Maeda, M, et al.. (2021). Bibliometric analysis of pharmacist’s research on antimicrobial stewardship in Japan: an interrupted time series analysis on the implementation of the certification system for infection control pharmacists. Journal of Pharmaceutical Health Care and Sciences. 7(1). 38–38. 9 indexed citations

14.

Kusama, Yoshiki, Masahiro Ishikane, Chika Tanaka, et al.. (2020). Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings. JAC-Antimicrobial Resistance. 2(1). dlaa004–dlaa004. 3 indexed citations

15.

Maeda, M, Yuichi Muraki, Tadashi Kosaka, et al.. (2020). Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs. Journal of Infection and Chemotherapy. 27(1). 1–6. 22 indexed citations

16.

Matsumoto, Takeshi, et al.. (2020). Impact of physician−pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study. Journal of Pharmaceutical Health Care and Sciences. 6(1). 9–9. 9 indexed citations

17.

Mizuno, Shugo, Yuichi Muraki, Kaname Nakatani, et al.. (2013). Immunological Aspects in Late Phase of Living Donor Liver Transplant Patients: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity. SHILAP Revista de lepidopterología. 2013. 1–8. 9 indexed citations

18.

Umemura, Takumi, Takahiro Mochizuki, Yuichi Muraki, et al.. (2010). . Japanese Journal of Infection Prevention and Control. 25(6). 376–382. 6 indexed citations

19.

Muraki, Yuichi, et al.. (2010). Evaluation of Hospital Information System-linked Notification System Concerning Usage of Broad-Spectrum Antimicrobials. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36(5). 316–322. 2 indexed citations

20.

Muraki, Yuichi, et al.. (2007). Establishment of Drug Information Training Program Based on "Model Core Curriculum for Practical Training"-Small Group Discussion by KJ Method and Debate in Simulated Meeting of Pharmaceutical Deliberation Committee-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(4). 347–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact